UK approves Pfizer/BioNTech Covid vaccine for emergency use in the country
The United Kingdom has become the first western country to license a vaccine against COVID-19, with the Pfizer/BioNTech vaccine to begin in those most at risk next week.
Google News'te Doğruhaber'e abone olun. 
Pfizer/BioNTech Covid has been approved for emergency use by the Medicines and Healthcare Products Regulatory Authority (MHRA), ahead of decisions by the US and Europe.
“Today’s Emergency Use Authorization in the U.K. marks a historic moment in the fight against COVID-19. This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the U.K.,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “As we anticipate further authorizations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world. With thousands of people becoming infected, every day matters in the collective race to end this devastating pandemic.”
“The Emergency Use Authorization in the U.K. will mark the first time citizens outside of the trials will have the opportunity to be immunized against COVID-19,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “We believe that the roll-out of the vaccination program in the U.K. will reduce the number of people in the high-risk population being hospitalized. Our aim is to bring a safe and effective vaccine upon approval to the people who need it. The data submitted to regulatory agencies around the world are the result of a scientifically rigorous and highly ethical research and development program.”
The MHRA’s decision is based on a rolling submission, including data from the Phase 3 clinical study, which demonstrated a vaccine efficacy rate of 95% (p
In July 2020, Pfizer and BioNTech announced an agreement with the U.K. to supply 30 million doses of the BNT162b2 mRNA-based vaccine, once authorized for emergency use. That agreement was increased to 40 million doses in early October.
The delivery of the 40 million doses will occur throughout 2020 and 2021, in stages, to ensure an equitable allocation of vaccines across the geographies with executed contracts. Now that the vaccine is authorized in the U.K., the companies will take immediate action to begin the delivery of vaccine doses.
The first doses are expected to arrive in the U.K. in the coming days, with complete delivery fulfilment expected in 2021. (ILKHA)
Bu haberler de ilginizi çekebilir
-
HÜDA PAR Deputy Chairman Şahzade Demir has criticized the recently announced 30% increase in the minimum wage, deeming it insufficient to address the current economic realities.
-
Syria's new leadership announced Tuesday that an agreement has been reached with rebel groups for their dissolution and subsequent integration into the country's regular armed forces.
